WHO estimates that 1 in 10 medicines circulating in low-income and middle-income countries (LMICs) is either substandard or falsified2. The ratio of substandard to falsified medical products is difficult to determine, but substandard or low-quality drugs are likely to account for the majority of SFMPs3.You are responsible for reporting use of this